FOXO3a-dependent PARKIN negatively regulates cardiac hypertrophy by restoring mitophagy
Open Access
- 19 December 2022
- journal article
- research article
- Published by Springer Nature in Cell & Bioscience
- Vol. 12 (1) , 1-19
Abstract
Background: Sustained cardiac hypertrophy often develops maladaptive myocardial remodeling, and eventually progresses to heart failure and sudden death. Therefore, maladaptive hypertrophy is considered as a critical therapeutic target for many heart diseases. Mitophagy, a crucial mechanism in mitochondria quality control and cellular homeostasis, has been implicated in diverse cardiac disorders such as myocardial infarction, diabetic cardiomyopathy, cardiac hypertrophy and heart failure. However, what role mitophagy plays in heart diseases remains an enigma. PARKIN functions as an E3 ubiquitin protein ligase and mediates mitophagy cascades. It is still unclear whether PARKIN participates in the regulation of cardiac hypertrophy. Results: PARKIN was downregulated in cardiomyocytes and hearts under hypertrophic stress. Enforced expression of PARKIN inhibited Ang II-induced cardiomyocyte hypertrophy. Compared to wide-type mice with Ang II-induced cardiac hypertrophy, Parkin transgenic mice subjected to Ang II administration showed attenuated cardiac hypertrophy and improved cardiac function. In addition, mitophagy machinery was impaired in response to Ang II, which was rescued by overexpression of PARKIN. PARKIN exerted the anti-hypertrophy effect through restoring mitophagy. In further exploring the underlying mechanisms, we found that PARKIN was transcriptionally activated by FOXO3a. FOXO3a promoted mitophagy and suppressed cardiac hypertrophy by targeting Parkin. Conclusions: The present study reveals a novel cardiac hypertrophy regulating model composed of FOXO3a, PARKIN and mitophagy program. Modulation of their levels may provide a new approach for preventing cardiac hypertrophy and heart failure. GraphicalKeywords
Funding Information
- National Natural Science Foundation of China (82170294, 81800268, 82170523)
- Central Government Guiding Local Science and Technology Development Fund Project (YDZJSX2022A061)
- Natural Science Foundation of Shanxi Province (20210302123346)
- Shanxi 1331 Project Quality and Efficiency Improvement Plan (XK201708)
This publication has 57 references indexed in Scilit:
- Non-coding RNAs in Cardiac Remodeling and Heart FailureCirculation Research, 2013
- miR-874 regulates myocardial necrosis by targeting caspase-8Cell Death & Disease, 2013
- FoxO1 and FoxM1 Transcription Factors Have Antagonistic Functions in Neonatal Cardiomyocyte Cell-Cycle Withdrawal and IGF1 Gene RegulationCirculation Research, 2013
- Parkin Protein Deficiency Exacerbates Cardiac Injury and Reduces Survival following Myocardial InfarctionJournal of Biological Chemistry, 2013
- JNK modulates FOXO3a for the expression of the mitochondrial death and mitophagy marker BNIP3 in pathological hypertrophy and in heart failureCell Death & Disease, 2012
- miR-484 regulates mitochondrial network through targeting Fis1Nature Communications, 2012
- PINK1 and Parkin Target Miro for Phosphorylation and Degradation to Arrest Mitochondrial MotilityCell, 2011
- Mitofusin 1 and mitofusin 2 are ubiquitinated in a PINK1/parkin-dependent manner upon induction of mitophagyHuman Molecular Genetics, 2010
- Foxo3a Inhibits Cardiomyocyte Hypertrophy through Transactivating CatalaseJournal of Biological Chemistry, 2008
- Essential role for Nix in autophagic maturation of erythroid cellsNature, 2008